Listed

Rapid Micro Biosystems, Inc.

RPIDNasdaqCIK 1380106TechnologyFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$8.1m, Q2 FY2026
Operating income−$12.3m, Q2 FY2026
Net income−$12.9m, Q2 FY2026
Rapid Micro Biosystems, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m6.1Revenue, Q3 FY2023, three months to 2023-09-30$6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure6.3Revenue, Q4 FY2023, three months to 2023-12-31$6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001380106-25-000058. Derived: 12-month figure less the 9-month figure.Report this figure5.6Revenue, Q1 FY2024, three months to 2024-03-31$5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure6.6Revenue, Q2 FY2024, three months to 2024-06-30$6.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure7.6Revenue, Q3 FY2024, three months to 2024-09-30$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure8.2Revenue, Q4 FY2024, three months to 2024-12-31$8.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure7.2Revenue, Q1 FY2025, three months to 2025-03-31$7.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure7.3Revenue, Q2 FY2025, three months to 2025-06-30$7.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure7.8Revenue, Q3 FY2025, three months to 2025-09-30$7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure11.3Revenue, Q4 FY2025, three months to 2025-12-31$11.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure8.0Revenue, Q1 FY2026, three months to 2026-03-31$8.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure8.1Revenue, Q2 FY2026, three months to 2026-06-30$8.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reported6.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$6.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure7.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$7.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figurenot reportednot reported7.6Cost of revenue, Q1 FY2026, three months to 2026-03-31$7.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure6.8Cost of revenue, Q2 FY2026, three months to 2026-06-30$6.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reported0.4Gross profit, Q1 FY2025, three months to 2025-03-31$404.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure0.3Gross profit, Q2 FY2025, three months to 2025-06-30$275.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figurenot reportednot reported0.4Gross profit, Q1 FY2026, three months to 2026-03-31$371.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure1.2Gross profit, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Research and development$m3.1Research and development, Q3 FY2023, three months to 2023-09-30$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure3.3Research and development, Q4 FY2023, three months to 2023-12-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-28, accession 0001380106-25-000058. Derived: 12-month figure less the 9-month figure.Report this figure3.8Research and development, Q1 FY2024, three months to 2024-03-31$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure3.7Research and development, Q2 FY2024, three months to 2024-06-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure3.6Research and development, Q3 FY2024, three months to 2024-09-30$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure3.4Research and development, Q4 FY2024, three months to 2024-12-31$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure3.6Research and development, Q1 FY2025, three months to 2025-03-31$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure3.2Research and development, Q2 FY2025, three months to 2025-06-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure3.5Research and development, Q3 FY2025, three months to 2025-09-30$3.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure3.2Research and development, Q4 FY2025, three months to 2025-12-31$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure3.4Research and development, Q1 FY2026, three months to 2026-03-31$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure3.3Research and development, Q2 FY2026, three months to 2026-06-30$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Operating income$m(14.4)Operating income, Q3 FY2023, three months to 2023-09-30−$14.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure(12.2)Operating income, Q4 FY2023, three months to 2023-12-31−$12.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-28, accession 0001380106-25-000058. Derived: 12-month figure less the 9-month figure.Report this figure(14.3)Operating income, Q1 FY2024, three months to 2024-03-31−$14.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure(13.4)Operating income, Q2 FY2024, three months to 2024-06-30−$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure(12.0)Operating income, Q3 FY2024, three months to 2024-09-30−$12.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure(10.2)Operating income, Q4 FY2024, three months to 2024-12-31−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(11.7)Operating income, Q1 FY2025, three months to 2025-03-31−$11.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure(12.1)Operating income, Q2 FY2025, three months to 2025-06-30−$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure(11.4)Operating income, Q3 FY2025, three months to 2025-09-30−$11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure(12.2)Operating income, Q4 FY2025, three months to 2025-12-31−$12.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(13.9)Operating income, Q1 FY2026, three months to 2026-03-31−$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure(12.3)Operating income, Q2 FY2026, three months to 2026-06-30−$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Interest expense$mnot reportednot reportednot reportednot reported0.0Interest expense, Q3 FY2024, three months to 2024-09-30$11.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$12.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$12.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$12.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure0.4Interest expense, Q3 FY2025, three months to 2025-09-30$393.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure0.7Interest expense, Q4 FY2025, three months to 2025-12-31$673.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure0.6Interest expense, Q1 FY2026, three months to 2026-03-31$639.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure0.6Interest expense, Q2 FY2026, three months to 2026-06-30$646.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$10.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-02-28, accession 0001380106-25-000058. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$15.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$13.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$9.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$14.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$45.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Net income$m(13.4)Net income, Q3 FY2023, three months to 2023-09-30−$13.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure(11.2)Net income, Q4 FY2023, three months to 2023-12-31−$11.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-28, accession 0001380106-25-000058. Derived: 12-month figure less the 9-month figure.Report this figure(13.3)Net income, Q1 FY2024, three months to 2024-03-31−$13.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure(12.6)Net income, Q2 FY2024, three months to 2024-06-30−$12.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure(11.3)Net income, Q3 FY2024, three months to 2024-09-30−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure(9.7)Net income, Q4 FY2024, three months to 2024-12-31−$9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(11.3)Net income, Q1 FY2025, three months to 2025-03-31−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure(11.9)Net income, Q2 FY2025, three months to 2025-06-30−$11.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure(11.5)Net income, Q3 FY2025, three months to 2025-09-30−$11.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure(12.5)Net income, Q4 FY2025, three months to 2025-12-31−$12.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(14.3)Net income, Q1 FY2026, three months to 2026-03-31−$14.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure(12.9)Net income, Q2 FY2026, three months to 2026-06-30−$12.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Diluted EPS$ per share(0.31)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure(0.29)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure(0.26)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figurenot reported(0.26)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure(0.27)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure(0.26)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure(0.27)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Basic EPS$ per share(0.31)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figurenot reported(0.31)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure(0.29)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure(0.26)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figurenot reported(0.26)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure(0.27)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure(0.26)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figurenot reported(0.31)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure(0.27)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure

Balance sheet

Cash and equivalents$14.7m, Q2 FY2026
Long-term debt$19.1m, Q2 FY2026
Shareholders' equity$17.7m, Q2 FY2026
Rapid Micro Biosystems, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m23.8Cash and equivalents, Q3 FY2023, at 2023-09-30$23.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-03, accession 0001380106-23-000177.Report this figure24.3Cash and equivalents, FY2023, at 2023-12-31$24.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-28, accession 0001380106-25-000058.Report this figure22.4Cash and equivalents, Q1 FY2024, at 2024-03-31$22.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-03, accession 0001380106-24-000127.Report this figure37.1Cash and equivalents, Q2 FY2024, at 2024-06-30$37.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-02, accession 0001380106-24-000166.Report this figure22.0Cash and equivalents, Q3 FY2024, at 2024-09-30$22.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure16.9Cash and equivalents, FY2024, at 2024-12-31$16.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001380106-26-000034.Report this figure18.9Cash and equivalents, Q1 FY2025, at 2025-03-31$18.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure18.3Cash and equivalents, Q2 FY2025, at 2025-06-30$18.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure18.9Cash and equivalents, Q3 FY2025, at 2025-09-30$18.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure20.0Cash and equivalents, FY2025, at 2025-12-31$20.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure13.8Cash and equivalents, Q1 FY2026, at 2026-03-31$13.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure14.7Cash and equivalents, Q2 FY2026, at 2026-06-30$14.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Current assets$m115Current assets, Q3 FY2023, at 2023-09-30$115.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-03, accession 0001380106-23-000177.Report this figure120Current assets, FY2023, at 2023-12-31$120.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-28, accession 0001380106-25-000058.Report this figure108Current assets, Q1 FY2024, at 2024-03-31$108.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-03, accession 0001380106-24-000127.Report this figure98.2Current assets, Q2 FY2024, at 2024-06-30$98.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-02, accession 0001380106-24-000166.Report this figure87.9Current assets, Q3 FY2024, at 2024-09-30$87.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure80.9Current assets, FY2024, at 2024-12-31$80.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001380106-26-000034.Report this figure69.2Current assets, Q1 FY2025, at 2025-03-31$69.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure60.1Current assets, Q2 FY2025, at 2025-06-30$60.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure70.0Current assets, Q3 FY2025, at 2025-09-30$70.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure61.2Current assets, FY2025, at 2025-12-31$61.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure49.2Current assets, Q1 FY2026, at 2026-03-31$49.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure46.3Current assets, Q2 FY2026, at 2026-06-30$46.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Total assets$m150Total assets, Q3 FY2023, at 2023-09-30$150.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0001380106-23-000177.Report this figure143Total assets, FY2023, at 2023-12-31$143.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0001380106-25-000058.Report this figure128Total assets, Q1 FY2024, at 2024-03-31$127.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-03, accession 0001380106-24-000127.Report this figure117Total assets, Q2 FY2024, at 2024-06-30$117.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-02, accession 0001380106-24-000166.Report this figure106Total assets, Q3 FY2024, at 2024-09-30$105.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure98.2Total assets, FY2024, at 2024-12-31$98.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001380106-26-000034.Report this figure85.4Total assets, Q1 FY2025, at 2025-03-31$85.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure75.6Total assets, Q2 FY2025, at 2025-06-30$75.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure84.4Total assets, Q3 FY2025, at 2025-09-30$84.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure74.9Total assets, FY2025, at 2025-12-31$74.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure62.4Total assets, Q1 FY2026, at 2026-03-31$62.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure58.5Total assets, Q2 FY2026, at 2026-06-30$58.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Current liabilities$m15.6Current liabilities, Q3 FY2023, at 2023-09-30$15.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-03, accession 0001380106-23-000177.Report this figure19.0Current liabilities, FY2023, at 2023-12-31$19.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-28, accession 0001380106-25-000058.Report this figure15.6Current liabilities, Q1 FY2024, at 2024-03-31$15.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-03, accession 0001380106-24-000127.Report this figure16.6Current liabilities, Q2 FY2024, at 2024-06-30$16.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-02, accession 0001380106-24-000166.Report this figure15.9Current liabilities, Q3 FY2024, at 2024-09-30$15.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure17.6Current liabilities, FY2024, at 2024-12-31$17.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001380106-26-000034.Report this figure15.0Current liabilities, Q1 FY2025, at 2025-03-31$15.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure16.4Current liabilities, Q2 FY2025, at 2025-06-30$16.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure16.5Current liabilities, Q3 FY2025, at 2025-09-30$16.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure18.5Current liabilities, FY2025, at 2025-12-31$18.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure19.1Current liabilities, Q1 FY2026, at 2026-03-31$19.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure18.2Current liabilities, Q2 FY2026, at 2026-06-30$18.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Total liabilities$m22.4Total liabilities, Q3 FY2023, at 2023-09-30$22.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-03, accession 0001380106-23-000177.Report this figure25.5Total liabilities, FY2023, at 2023-12-31$25.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-28, accession 0001380106-25-000058.Report this figure21.8Total liabilities, Q1 FY2024, at 2024-03-31$21.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-03, accession 0001380106-24-000127.Report this figure22.5Total liabilities, Q2 FY2024, at 2024-06-30$22.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-02, accession 0001380106-24-000166.Report this figure21.5Total liabilities, Q3 FY2024, at 2024-09-30$21.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure22.8Total liabilities, FY2024, at 2024-12-31$22.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001380106-26-000034.Report this figure19.9Total liabilities, Q1 FY2025, at 2025-03-31$19.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure21.0Total liabilities, Q2 FY2025, at 2025-06-30$21.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure40.1Total liabilities, Q3 FY2025, at 2025-09-30$40.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure41.6Total liabilities, FY2025, at 2025-12-31$41.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure42.0Total liabilities, Q1 FY2026, at 2026-03-31$42.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure40.7Total liabilities, Q2 FY2026, at 2026-06-30$40.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reported0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-12, accession 0001380106-26-000034.Report this figurenot reportednot reported18.8Long-term debt, Q3 FY2025, at 2025-09-30$18.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure18.9Long-term debt, FY2025, at 2025-12-31$18.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure19.1Long-term debt, Q1 FY2026, at 2026-03-31$19.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure19.1Long-term debt, Q2 FY2026, at 2026-06-30$19.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure
Shareholders' equity$m128Shareholders' equity, Q3 FY2023, at 2023-09-30$127.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure118Shareholders' equity, FY2023, at 2023-12-31$118.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001380106-26-000034.Report this figure106Shareholders' equity, Q1 FY2024, at 2024-03-31$105.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure94.6Shareholders' equity, Q2 FY2024, at 2024-06-30$94.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure84.4Shareholders' equity, Q3 FY2024, at 2024-09-30$84.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure75.4Shareholders' equity, FY2024, at 2024-12-31$75.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure65.5Shareholders' equity, Q1 FY2025, at 2025-03-31$65.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure54.5Shareholders' equity, Q2 FY2025, at 2025-06-30$54.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure44.3Shareholders' equity, Q3 FY2025, at 2025-09-30$44.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure33.2Shareholders' equity, FY2025, at 2025-12-31$33.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure20.4Shareholders' equity, Q1 FY2026, at 2026-03-31$20.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure17.7Shareholders' equity, Q2 FY2026, at 2026-06-30$17.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure

Cash flow

Operating cash flow−$12.7m, Q2 FY2026
Capital expenditure−$223.0k, Q2 FY2026
Rapid Micro Biosystems, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(9.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$9.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001380106-24-000197. Derived: 9-month figure less the 6-month figure.Report this figure(9.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$9.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-28, accession 0001380106-25-000058. Derived: 12-month figure less the 9-month figure.Report this figure(15.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$15.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure(10.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001380106-25-000174. Derived: 6-month figure less the 3-month figure.Report this figure(8.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$8.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001380106-25-000200. Derived: 9-month figure less the 6-month figure.Report this figure(9.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(9.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure(9.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$9.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001380106-26-000101. Derived: 6-month figure less the 3-month figure.Report this figure(9.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001380106-25-000200. Derived: 9-month figure less the 6-month figure.Report this figure(3.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(15.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$15.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure(12.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$12.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001380106-26-000101. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$453.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001380106-24-000197. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$418.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-28, accession 0001380106-25-000058. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$585.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure0.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$459.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001380106-25-000174. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$223.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001380106-25-000200. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$98.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$319.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure0.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$366.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001380106-26-000101. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$73.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001380106-25-000200. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$92.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001380106-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2026, three months to 2026-03-31$394.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure(0.2)Capital expenditure, Q2 FY2026, three months to 2026-06-30−$223.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001380106-26-000101. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)48.35m, Q2 FY2026
Rapid Micro Biosystems, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares42.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3042,517,992 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0001380106-23-000177.Report this figure42.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3142,812,580 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-03, accession 0001380106-24-000127.Report this figure43.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3043,059,937 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-02, accession 0001380106-24-000166.Report this figure43.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3043,080,095 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001380106-24-000197.Report this figure43.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3143,245,835 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0001380106-25-000102.Report this figure43.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3043,616,501 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001380106-25-000174.Report this figure43.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3043,668,656 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure44.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3143,993,359 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure44.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3044,648,602 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure45.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3044,956,131 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001380106-25-000200.Report this figure45.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3145,433,800 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001380106-26-000075.Report this figure48.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3048,346,663 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001380106-26-000101.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.